ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

In today's ACT Brief, we examine value hidden in the RBQM financial model, why rare disease research leads on genuine patient partnership, and how safety concerns shape IBD treatment decisions despite clinical efficacy.